TERT and hepatocellular carcinoma: TERT promoter mutations have been identified in 6% of low-grade dysplastic nodules, 19% of high-grade dysplastic nodules, 61% of early hepatocellular carcinomas, and 42% of small and progressed HCC, correlating with step-wise development of hepatocarcinogenesis.